Do phosphodiesterase 5 inhibitors improve exercise capacity in patients with COPD associated pulmonary hypertension? (3P study)

A. Goudie, P. Hopkinson, B. Lipworth, A. Struthers (Dundee, United Kingdom)

Source: Annual Congress 2013 –Pulmonary circulation: clinical treatment
Session: Pulmonary circulation: clinical treatment
Session type: Thematic Poster Session
Number: 4063
Disease area: Airway diseases, Pulmonary vascular diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Goudie, P. Hopkinson, B. Lipworth, A. Struthers (Dundee, United Kingdom). Do phosphodiesterase 5 inhibitors improve exercise capacity in patients with COPD associated pulmonary hypertension? (3P study). Eur Respir J 2013; 42: Suppl. 57, 4063

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Arm activity in daily life in chronic obstructive pulmonary disease (COPD)
Source: International Congress 2014 – Exercise training and physical activity in patients with COPD
Year: 2014


Impact of riociguat on health-related quality of life (HRQoL) in patients with chronic thromboembolic pulmonary hypertension (CTEPH)
Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment
Year: 2013


A pilot study to assess the efficacy of breathlessness plans for patients with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2016 – COPD diagnosis and management
Year: 2016

The pulmonary artery-aorta ratio, exacerbation rate and quality of life in stable COPD patients
Source: International Congress 2016 – Exploring mechanisms in health and disease
Year: 2016


Impact on quality of life and general health of three types of pulmonary rehabilitation: Endurance, resistance and combined training in chronic obstructive pulmonary disease (COPD) patients in Costa Rica
Source: Annual Congress 2013 –The latest insights in pulmonary rehabilitation (part 2)
Year: 2013


Long-term efficacy of repeated pulmonary rehabilitation programs (PRP) in chronic airway obstruction (CAO)
Source: Annual Congress 2005 - Pulmonary rehabilitation: an evidence-based intervention
Year: 2005


Relationship of quality of life and life expectancy with tolerance to physical exercises and cardio respiratory parameters in patients with pulmonary arterial hypertension
Source: Annual Congress 2013 –Novel biomarkers and old parameters in clinical management of lung diseases
Year: 2013

Relationship between patient pulmonary function, exercise capacity and quality of life in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2012 - New issues in pulmonary function
Year: 2012

LATE-BREAKING ABSTRACT: Antioxidant supplementation in chronic obstructive pulmonary disease (COPD): A relevant way to optimize pulmonary rehabilitation effects
Source: International Congress 2016 – Latest insights into functional capacity and muscle weakness in chronic lung diseases
Year: 2016

Quality of life in patients with chronic obstructive pulmonary disease (COPD) and long-term oxygen therapy (LTOT)
Source: Eur Respir J 2001; 18: Suppl. 33, 486s
Year: 2001

Self-conscious emotions in patients with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2014 – Physical activity, exercise and physiotherapy in COPD and asthma
Year: 2014

Chronic obstructive pulmonary disease assessment test (CAT) in patients with COPD, chronic heart failure (CHF), and both
Source: International Congress 2016 – Features and impact of comorbidities in COPD
Year: 2016

Seasonal variations in exercise tolerance, activity and quality of life in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2005 - Pulmonary rehabilitation: an evidence-based intervention
Year: 2005


Experiences of well-being when living with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2014 – Qualitative and quantitative research that contributes to respiratory nursing practice
Year: 2014


Is anxiety and depression a barrier to enrolment in a study in chronic obstructive pulmonary disease (COPD)?
Source: International Congress 2016 – Kaleidoscope of respiratory nursing
Year: 2016

An exploration of pain experiences and their meaning in people with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2016 – Postural balance, respiratory muscles, and comorbidities in chronic respiratory disease
Year: 2016


Quality of life (QL) depending on psychological disorders (PD) of patients with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2014 – Comorbidities
Year: 2014


Impact of riociguat on health-related quality of life (HRQoL) in patients with pulmonary arterial hypertension (PAH)
Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment
Year: 2013


Quality of life and disease burden of chronic obstructive pulmonary disease (COPD) patients in Northern Greece – The INCARE* study
Source: International Congress 2015 – Management of COPD and other respiratory diseases in primary care
Year: 2015


Economic effectiveness of integrated care model (ICM) for patients with severe chronic obstructive pulmonary disease (COPD)
Source: International Congress 2015 – Patient health gains related to the economic effectiveness of disease management programmes
Year: 2015